{
    "organizations": [],
    "uuid": "8041338bf9b72c6b14cc1d778c821992a678054b",
    "author": "",
    "url": "https://www.reuters.com/article/brief-vbi-vaccines-posts-positive-dsmb-r/brief-vbi-vaccines-posts-positive-dsmb-review-of-recurrent-glioblastoma-study-idUSFWN1RU0TJ",
    "ord_in_thread": 0,
    "title": "BRIEF-VBI Vaccines Posts Positive DSMB Review Of Recurrent Glioblastoma Study",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 13 PM / Updated 24 minutes ago BRIEF-VBI Vaccines Posts Positive DSMB Review Of Recurrent Glioblastoma Study Reuters Staff 1 Min Read \nApril 17 (Reuters) - VBI Vaccines Inc: \n* VBI VACCINES ANNOUNCES POSITIVE DSMB REVIEW IN PHASE 1/2A STUDY OF VBI-1901 IN RECURRENT GLIOBLASTOMA (GBM) PATIENTS \n* VBI VACCINES INC - INDEPENDENT DATA AND SAFETY MONITORING BOARD UNANIMOUSLY RECOMMENDS CONTINUATION OF STUDY WITHOUT MODIFICATION \n* VBI VACCINES INC - INITIATED ENROLLMENT IN INTERMEDIATE-DOSE ARM OF DOSE-ESCALATION PHASE OF STUDY Source text for Eikon: Further company coverage:",
    "published": "2018-04-17T15:13:00.000+03:00",
    "crawled": "2018-04-17T15:31:22.009+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "pm",
        "updated",
        "minute",
        "ago",
        "vaccine",
        "post",
        "positive",
        "dsmb",
        "review",
        "recurrent",
        "glioblastoma",
        "study",
        "reuters",
        "staff",
        "min",
        "read",
        "april",
        "reuters",
        "vbi",
        "vaccine",
        "inc",
        "vbi",
        "vaccine",
        "announces",
        "positive",
        "dsmb",
        "review",
        "phase",
        "study",
        "recurrent",
        "glioblastoma",
        "gbm",
        "patient",
        "vbi",
        "vaccine",
        "inc",
        "independent",
        "data",
        "safety",
        "monitoring",
        "board",
        "unanimously",
        "recommends",
        "continuation",
        "study",
        "without",
        "modification",
        "vbi",
        "vaccine",
        "inc",
        "initiated",
        "enrollment",
        "arm",
        "phase",
        "study",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}